help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Casey, M. L.
Right arrow Articles by MacDonald, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Casey, M. L.
Right arrow Articles by MacDonald, P. C.

Journal of Clinical Endocrinology & Metabolism, Vol 77, 144-150, Copyright © 1993 by Endocrine Society

ARTICLES

Transforming growth factor-beta 1 inhibits enkephalinase (EC 3.4.24.11) gene expression in human endometrial stromal cells and sex skin fibroblasts in culture

ML Casey, JW Smith, K Nagai and PC MacDonald
Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas 75235.

This study was conducted to evaluate the negative regulation of enkephalinase by an endogenously produced peptide, namely transforming growth factor-beta 1 (TGF beta 1). We found that TGF beta 1 acts in human endometrial stromal cells and sex skin fibroblasts in culture to cause a striking decrease (60% to > 90% in 3-7 days) in the specific activity of enkephalinase (membrane metalloendopeptidase; EC 3.4.24.11) by reducing the levels of enkephalinase mRNA and protein. Platelet- derived growth factor caused a slight reduction in enkephalinase specific activity in endometrial stromal cells; epidermal growth factor caused a slight decrease in enkephalinase specific activity in sex skin fibroblasts. In studies in which TGF beta 1 treatment and [35S]methionine labeling were conducted simultaneously, radiolabeling of enkephalinase was decreased. When proteins were radiolabeled with [35S] methionine before treatment with TGF beta 1, the extent of enkephalinase radiolabeling was similar to that in nontreated cells. These findings are indicative that TGF beta 1 acts to decrease enkephalinase activity by a reduction in gene transcription or mRNA stability and not by accelerated degradation of enkephalinase protein.


This article has been cited by other articles:


Home page
 Reproductive SciencesHome page
D. S. McKenna, P. Samuels, P. D. Zimmerman, and D. A. Kniss
Interleukin-I{alpha}, Epidermal Growth Factor, and Transforming Growth Factor-{beta} Exhibit Differential Kinetics on Endothelin-I Synthesis in Amnion Cells
Reproductive Sciences, January 1, 1998; 5(1): 25 - 30.
[Abstract] [PDF]

Home page
 DevelopmentHome page
B Spencer-Dene, P Thorogood, S Nair, A. Kenny, M Harris, and B Henderson
Distribution of, and a putative role for, the cell-surface neutral metallo-endopeptidases during mammalian craniofacial development
Development, January 11, 1994; 120(11): 3213 - 3226.
[Abstract] [PDF]

Home page
 J. Cell Sci.Home page
A. Atherton, M. O'Hare, L Buluwela, J Titley, P Monaghan, H. Paterson, M. Warburton, and B. Gusterson
Ectoenzyme regulation by phenotypically distinct fibroblast sub-populations isolated from the human mammary gland
J. Cell Sci., January 10, 1994; 107(10): 2931 - 2939.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society